Leaflet LEUJECT 2mg / ml solution for injection
Indicated for: multiple sclerosis; chronic lymphocytic leukemia
Route of administration: injectable
Substance: cladribine (antimetabolite antineoplastic)
ATC: L01BB04 (Antineoplastic and immunomodulating agents | Antimetabolites | Purine analogues)
This medicine may affect fertility.
Dose adjustment may be needed in liver disease.
Handle with special care.
Effective contraception is required during treatment.
Do not use this medicine while breastfeeding.
Do not use this medicine during pregnancy.
This medicine may affect the liver.
This medicine may have important interactions with other medicines.
This medicine may lower blood cell counts.
This medicine is subject to additional monitoring.
Periodic laboratory tests may be required during treatment.
Stop taking the medicine and seek urgent medical help if a severe rash occurs.
Cladribine is a medication used to treat hairy cell leukemia and relapsing multiple sclerosis. It works by inhibiting DNA synthesis in rapidly dividing cells, such as cancer cells or overactive immune cells.
The medication is administered either as injections or tablets, depending on the therapeutic indication. It is important to use it as prescribed by your doctor to achieve the best results.
Side effects may include nausea, fatigue, fever, decreased blood cell counts, and an increased risk of infections. In rare cases, severe allergic reactions or other complications may occur, requiring immediate medical attention.
Patients should inform their doctor about any other medications being used or pre-existing conditions, such as active infections or liver diseases, as these may affect the safety of cladribine use.
General data about LEUJECT 2mg / ml
- Substance: cladribine
- Date of last drug list: 01-04-2025
- Commercial code: W70932001
- Concentration: 2mg / ml
- Pharmaceutical form: solution for injection
- Quantity: 1
- Product type: generic
- Prescription restrictions: P-RF - Medicines prescription that is retained in the pharmacy (not renewable).
Pharmaceutical forms available for cladribine
Concentrations available for cladribine
- 10mg
- 2mg/ml